Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia

Blood

Volumn 93, Issue 9, 1999, Pages 2780-2790

  Honda, Hiroaki ^b   Inaba, Toshiya ^b   Suzuki, Takahiro ^b   Oda, Hideaki ^b   Ebihara, Yasuhiro ^b   Tsuiji, Kohichiro ^b   Nakahata, Tatsutoshi ^b   Ishikawa, Takatoshi ^b   Yazaki, Yoshio ^b   Hirai, Hisamaru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL MATURATION; CHIMERA; CHROMOSOME TRANSLOCATION; COLONY FORMATION; DIMERIZATION; FLOW CYTOMETRY; FUSION GENE; GENE REARRANGEMENT; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 0033135718     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.9.2780.409a47_2780_2790     Document Type: Article

References (42)

1. Rabbitts TH: Chromosomal translocations in human cancer [review]. Nature 372:143, 1994
2. Cleary ML: Oncogenic conversion of transcription factors by chromosomal translocations. Cell 66:619, 1991
3. Kamps MP, Murre C, Sun XH, Baltimore D: A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60:547, 1990
4. Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML: Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60:535, 1990
5. Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD, Look AT: Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 257:531, 1992
6. Hunger SP, Ohyashiki K, Toyama K, Cleary ML: HLF, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev 6:1608, 1992
7. Murre C, McCaw PS, Baltimore D: A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777, 1989
8. Roberts VJ, Steenbergen R, Murre C: Localization of E2A mRNA expression in developing and adult rat tissues. Proc Natl Acad Sci USA 90:7583, 1993
9. Inaba T, Shapiro LH, Funabiki T, Sinclair AE, Jones BG, Ashmun RA, Look AT: DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein. Mol Cell Biol 14:3403, 1994
10. Yoshihara T, Inaba T, Shapiro LH, Kato JY, Look AT: E2A-HLF-mediated cell transformation requires both the trans-activation domains of E2A and the leucine zipper dimerization domain of HLF. Mol Cell Biol 15:3247, 1995
11. Inaba T, Inukai T, Yoshihara T, Seyschab H, Ashmun RA, Canman CE, Laken SJ, Kastan MB, Look AT: Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor. Nature 382:541, 1996
12. Look AT: E2A-HLF chimeric transcription factors in pro-B cell acute lymphoblastic leukemia. Curr Top Microbiol Immunol 220:45, 1997
13. bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice. Blood 85:2853, 1995
14. Akasaka T, Tsuji K, Kawahira H, Kanno M, Harigaya K, Hu L, Ebinata Y, Nakahata T, Tetsu O, Taniguchi M, Koseki H: The role of mel-18, a mammalian Polycomb group gene, during IL-7-dependent proliferation of lymphocyte precursors. Immunity 7:135, 1997
15. Chomczinski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
16. Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H, Wick G: Simultaneous determination of cell surface antigens and apoptosis. Trends Genet 10:41, 1994
17. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K: Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 173:1213, 1991
18. Adams JM, Cory S: Transgenic models of tumor development. Science 254:1161, 1991
19. Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK, Groffen J: Acute leukaemia in bcr/abl transgenic mice. Nature 344:251, 1990
20. 1-positive leukemias. Blood 91:2067, 1998
21. Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S, Bishop JM: A PML/RARα transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci USA 94:2551, 1997
22. He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, Pandolfi PP: Acute leukemia with promyelocytic features in PML/RARα transgenic mice. Proc Natl Acad Sci USA 94:5302, 1997
23. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD, Brinster RL: The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:533, 1985
24. Yukawa K, Kikutani H, Inomoto T, Uehira M, Bin SH, Akagi K, Yamamura K, Kishimoto T: Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (Eμ)-myc transgenic mice. J Exp Med 170:711, 1989
25. Moroy T, Fisher P, Guidos C, Ma A, Zimmerman K, Tesfaye A, DePinho R, Weissman I, Alt FW: IgH enhancer deregulated expression of L-myc: Abnormal T lymphocyte development and T cell lymphomagenesis. EMBO J 9:3659, 1990
26. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693, 1992
27. Tsujimoto Y, Finger LR, Yunis J, C. NP, Croce CM: Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226:1097, 1984
28. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
29. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
30. Inukai T, Inaba T, Ikushima S, Look AT: The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the E2A-HLF chimeric oncoprotein. Mol Cell Biol 18:6035, 1998
31. Goi K, Kurosawa H, Inaba T, Meltzer PS, Look AT: Downstream target genes for E2A-HLF indentified by cDNA microarray analysis. Blood 92:590a, 1998 (abstr, suppl 1)
32. Dedera DA, Waller EK, LeBrun DP, Sen-Majumdar A, Stevens ME, Barsh GS, Cleary ML: Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell 74:833, 1993
33. Lu Q, Wright DD, Kamps MP: Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation. Mol Cell Biol 14:3938, 1994
34. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van Roon M, van der Valk M, te Riele HPJ, Berns A, Murre C: E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885, 1994
35. Zhuang Y, Soriano P, Weintraub H: The helix-loop-helix gene E2A is required for B cell formation. Cell 79:875, 1994
36. Bain G, Engel I, Robanus Maandag EC, te Riele HP, Voland JR, Sharp LL, Chun J, Huey B, Pinkel D, Murre C: E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol 17:4782, 1997
37. Inukai T, Inaba T, Yoshihara T, Look AT: Cell transformation mediated by homodimeric E2A-HLF transcription factor. Mol Cell Biol 17:1413, 1997
38. Monica K, LeBrun DP, Dedera DA, Brown R, Cleary ML: Transformation properties of the E2a-Pbx1 chimeric oncoprotein: Fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol Cell Biol 14:8304, 1994
39. Kamps MP, Wright DD, Lu Q: DNA-binding by oncoprotein E2A-Pbx1 is important for blocking differentiation but dispensable for flbroblast transformation. Oncogene 12:19, 1996
40. Hsu HL, Cheng JT, Chen Q, Baer R: Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol Cell Biol 11:3037, 1991
41. Hsu HL, Wadman I, Baer R: Formation of in vivo complexes between the Tall and E2A polypeptides of leukemic T cells. Proc Natl Acad Sci USA 91:3181, 1994
42. Larson RC, Lavenir I, Larson TA, Baer R, Warren AJ, Wadman I, Nottage K, Rabbitts TH: Protein dimerization between Lmo2 (Rbtn2) and Tall alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J 15:1021, 1996